Flying rocket

Hindustan Foods Ltd

Hindustan Foods Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Hindustan Foods Ltd

₹ 610 3.83%
31 Oct - close price
hindustanfoodslimited.com BSE: 519126 NSE: HNDFDS
About

Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories

Key Points

Acquired by Van group[1] Hindustan Food Limited (HFL) started a joint venture between Glaxo Smith Kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd was acquired by Vanity Case India Pvt. Ltd., and the latter bought 74.45% of the paid-up share capital.

Website BSE NSE
  • Market Cap ₹ 6,992 Cr.
  • Current Price ₹ 610
  • High / Low ₹ 686 / 461
  • Stock P/E 86.8
  • Book Value ₹ 54.8
  • Dividend Yield 0.00 %
  • ROCE 14.4 %
  • ROE 15.7 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has delivered good profit growth of 45.8% CAGR over last 5 years
  • Company's median sales growth is 56.9% of last 10 years

Cons

  • Stock is trading at 11.1 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Diversified - Large

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
457 471 527 562 565 597 627 595 534 585 643 620 640
431 442 498 531 532 561 587 557 498 544 597 580 594
Operating Profit 26 29 29 31 33 36 40 38 36 41 46 40 46
OPM % 6% 6% 6% 6% 6% 6% 6% 6% 7% 7% 7% 6% 7%
1 1 2 1 1 1 1 2 1 2 2 5 5
Interest 5 5 5 4 6 7 7 7 7 8 10 13 12
Depreciation 5 6 6 6 7 7 7 7 8 8 9 13 12
Profit before tax 17 19 19 22 21 23 27 25 22 27 28 19 27
Tax % 35% 36% 35% 34% 35% 26% 35% 36% 19% 19% 21% 14% 26%
11 12 13 15 14 17 17 16 18 22 23 16 20
EPS in Rs 1.05 1.15 1.18 1.29 1.23 1.50 1.54 1.45 1.58 1.91 2.00 1.43 1.75
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
6 3 17 24 38 139 492 772 1,407 2,021 2,383 2,381 2,487
6 4 23 22 35 128 459 716 1,317 1,905 2,236 2,219 2,314
Operating Profit -0 -0 -6 2 3 10 33 56 90 115 147 163 173
OPM % -0% -15% -33% 9% 8% 7% 7% 7% 6% 6% 6% 7% 7%
0 0 11 0 0 1 1 1 3 5 5 10 13
Interest 1 1 2 1 1 1 8 11 19 20 27 38 42
Depreciation 0 0 1 1 1 1 7 11 19 24 29 39 42
Profit before tax -1 -1 2 -0 1 9 18 35 54 77 96 96 101
Tax % 4% 0% 0% -2,980% 19% 27% 35% 34% 28% 35% 33% 19%
-1 -1 2 1 1 6 12 23 39 50 65 78 81
EPS in Rs -0.48 -0.53 1.00 0.58 0.10 0.97 1.76 2.14 3.71 4.44 5.72 6.83 7.09
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 94%
5 Years: 37%
3 Years: 19%
TTM: 6%
Compounded Profit Growth
10 Years: 51%
5 Years: 46%
3 Years: 26%
TTM: 18%
Stock Price CAGR
10 Years: 48%
5 Years: 38%
3 Years: 18%
1 Year: 18%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 17%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 5 5 5 5 13 13 13 21 21 23 23 23
Reserves -8 -9 -7 -5 19 24 51 166 235 285 349 605
17 18 11 13 5 34 100 165 219 274 349 508
4 6 8 7 13 46 102 188 265 305 356 402
Total Liabilities 19 20 17 19 50 118 266 540 741 886 1,076 1,537
4 8 9 9 9 39 133 250 308 396 402 593
CWIP 5 3 2 2 3 3 0 26 53 9 45 5
Investments 0 0 0 0 0 0 0 3 3 7 80 84
10 9 6 8 38 75 133 261 377 474 549 855
Total Assets 19 20 17 19 50 118 266 540 741 886 1,076 1,537

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-1 3 1 1 -5 -5 -5 17 73 54 102 48
-5 -3 -1 -1 -14 -19 -40 -145 -91 -103 -167 -347
6 -0 0 0 24 26 43 153 34 32 47 294
Net Cash Flow 0 -0 0 0 5 2 -2 24 16 -17 -18 -6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Sep 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 224 390 47 56 66 76 32 18 13 13 13 15
Inventory Days 136 295 108 37 90 139 54 74 58 52 61 87
Days Payable 183 387 184 103 166 237 85 94 74 60 58 67
Cash Conversion Cycle 177 298 -29 -10 -10 -21 1 -2 -3 5 16 35
Working Capital Days 134 107 -9 13 36 51 6 11 16 25 27 55
ROCE % -2% -6% 34% 8% 7% 19% 22% 18% 18% 18% 19% 14%

Shareholding Pattern

Numbers in percentages

3 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
62.62% 64.85% 64.85% 64.85% 64.85% 64.85% 64.85% 64.85% 64.85% 63.82% 63.82% 63.82%
6.50% 6.13% 6.04% 6.04% 6.57% 6.56% 6.59% 6.58% 6.70% 6.70% 3.02% 3.39%
6.92% 6.53% 6.53% 6.55% 6.55% 6.64% 6.58% 6.03% 5.96% 7.18% 13.43% 13.79%
23.95% 22.50% 22.59% 22.56% 22.04% 21.94% 22.00% 22.54% 22.50% 22.30% 19.73% 19.00%
No. of Shareholders 38,44637,07838,45950,57653,71160,48969,98880,58786,14785,36484,13679,846

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls